Clinical Trials in North Carolina

Showing 1021-1040 of 20,428 trials

Comparing the Effects of Front-of-Package Labeling Schemes in Indonesia

NCT07526584

The goal of this study is to examine what type of front-of-package label (FOPL) would be most effective at discouraging consumption of products high in nutrients of concern in Indonesia. The main questions this experiment aims to answer are: 1. Would nutrient warning labels be more effective at discouraging consumption of products high in nutrients of concern compared to the Nutri-Level label? 2. Would nutrient warning labels improve consumers' ability to identify unhealthy products compared to the Nutri-Level label? Additionally, this experiment also aims to determine how should nutrient warning labels be designed to most effectively discourage consumption of products high in nutrients of concern among Indonesian consumers.

NutritionObesity & Overweight

University of North Carolina, Chapel Hill1,000 participantsStarted Apr 2026

Chapel Hill, North Carolina, United States

COMPLETEDPhase 246 miles

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06049017

The purpose of this study is to evaluate the safety and effectiveness of JNJ-77242113 compared with placebo in participants with moderately to severely active ulcerative colitis.

Colitis, Ulcerative

Janssen Research & Development, LLC252 participantsStarted Oct 2023

Anaheim, California, United States • Newport Beach, California, United States • San Diego, California, United States +174 more locations

Comparing the Effects of Front-of-Package Labeling Schemes in Indonesia

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

Find Trials by Condition in North Carolina

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

A Study of XMT-1660 in Participants With Solid Tumors

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

Savolitinib vs. Sunitinib in MET-driven PRCC.

A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine

A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

A Study of Lu AF82422 in Participants With Multiple System Atrophy

A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma